These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12235860)

  • 21. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells.
    Hyuga S; Shiraishi M; Hori A; Hyuga M; Hanawa T
    Biol Pharm Bull; 2012; 35(10):1729-39. PubMed ID: 23037162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics.
    Homma M; Oka K; Ikeshima K; Takahashi N; Niitsuma T; Fukuda T; Itoh H
    J Pharm Pharmacol; 1995 Aug; 47(8):687-92. PubMed ID: 8583374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hasty effect on the metabolism of glycyrrhizin by Eubacterium sp. GLH with Ruminococcus sp. PO1-3 and Clostridium innocuum ES24-06 of human intestinal bacteria.
    Akao T
    Biol Pharm Bull; 2000 Jan; 23(1):6-11. PubMed ID: 10706402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biologically Active Constituents of Natural Medicines -A Mixture Can Do More].
    Kiuchi F
    Yakugaku Zasshi; 2022; 142(6):629-639. PubMed ID: 35650083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the major metabolites of hyperoside produced by the human intestinal bacteria using the ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Yang J; Qian D; Guo J; Jiang S; Shang EX; Duan JA; Xu J
    J Ethnopharmacol; 2013 May; 147(1):174-9. PubMed ID: 23458919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein.
    Matsumoto T; Kaifuchi N; Mizuhara Y; Warabi E; Watanabe J
    J Nat Med; 2018 Sep; 72(4):897-904. PubMed ID: 29797179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Marketing Approval of Ethical Kampo Medicines].
    Hakamatsuka T
    Yakugaku Zasshi; 2017; 137(2):163-165. PubMed ID: 28154326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Scientific Evaluation of Crude Drugs and Kampo Medicines Using the Eastern Blotting Method and Its Application to Biological Metabolic Studies].
    Morinaga O
    Yakugaku Zasshi; 2018; 138(6):743-750. PubMed ID: 29863039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kampo medicines as useful therapeutic agents in clinical practice of neurology: case reports & representative medicines].
    Ishida K
    Rinsho Shinkeigaku; 2013; 53(11):938-41. PubMed ID: 24291839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Kampo herbal medicines on murine water metabolism in a microgravity environment.
    Song QH; Toriizuka K; Kobayashi T; Iijima K; Hong T; Cyong JC
    Am J Chin Med; 2002; 30(4):617-27. PubMed ID: 12568289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines.
    Motoo Y; Arai I; Hyodo I; Tsutani K
    Complement Ther Med; 2009 Jun; 17(3):147-54. PubMed ID: 19398068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characteristics of Kampo medicine as a mixture of constituents and ingredients.
    Satoh H
    J Integr Med; 2013 Jan; 11(1):11-6. PubMed ID: 23464641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer effect of a Kampo preparation Daikenchuto.
    Nagata T; Toume K; Long LX; Hirano K; Watanabe T; Sekine S; Okumura T; Komatsu K; Tsukada K
    J Nat Med; 2016 Jul; 70(3):627-33. PubMed ID: 27059786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kampo pharmacology: Kampo medicines as a complementary and alternative medicine (CAM)].
    Satoh H
    Nihon Yakurigaku Zasshi; 2012 Aug; 140(2):54-7. PubMed ID: 22878566
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of antibiotic preparations and their combinations with probiotics on the intestinal microflora of mice].
    Furzikova TM; Sorokulova IB; Serhiĭchuk MH; Sichkar SV; Smirnov VV
    Mikrobiol Z; 2000; 62(3):26-35. PubMed ID: 10932540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.
    Shirayama R; Shoji M; Sriwilaijaroen N; Hiramatsu H; Suzuki Y; Kuzuhara T
    Drug Discov Ther; 2016; 10(2):109-13. PubMed ID: 26902927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction of effective ingredients from traditional Chinese medicines with intestinal microbiota].
    Zu XP; Lin Z; Xie HS; Yang N; Liu XR; Zhang WD
    Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1766-1772. PubMed ID: 28895319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Education Program of Kampo-medicine for Undergraduates in Preparation for Clinical Setting].
    Homma M
    Yakugaku Zasshi; 2016; 136(3):417-22. PubMed ID: 26935080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1.
    Iijima R; Watanabe T; Ishiuchi K; Matsumoto T; Watanabe J; Makino T
    J Ethnopharmacol; 2018 Mar; 214():153-159. PubMed ID: 29248449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria.
    Ahn YJ; Lee CO; Kweon JH; Ahn JW; Park JH
    J Appl Microbiol; 1998 Mar; 84(3):439-43. PubMed ID: 9721649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.